|
According to a survey distributed by The North American Menopause Society (NAMS), while 98 percent of women who participated consider bone strength to be an important health concern, nearly half (45 percent) of these women reported that osteoporosis was not addressed during their last routine OB/GYN visit, and more than a quarter (26.4 percent) of women surveyed have never discussed osteoporosis with their OB/GYN. More than 880 women completed the NAMS consumer survey, which assessed how they discuss osteoporosis with their OB/GYNs.
Osteoporosis is a silent disease that affects millions of postmenopausal women, making their bones weak and more likely to fracture over time. In fact, in the US today, 8 million women are estimated to already have osteoporosis, and almost 27 million more are estimated to have low bone mass, placing them at increased risk for fracture. It is estimated that women experience more osteoporosis-related fractures every year than have heart attacks, strokes, and breast cancer combined. The good news is that there are prescription medications available that effectively reduce both spinal and nonspinal fracture risk.
The online survey was fielded via email to subscribers of The North American Menopause Society consumer e-newsletter, Menopause Flashes. The survey, which included 21 close-ended questions, was deployed on September 24, 2009, and the deadline for responses was October 31. Emails were sent to a total of 27,895 subscribers to Menopause Flashes and 1,627 responses were collected. From the pool of respondents, a total of 881 US women currently under the care of an OB/GYN completed the survey. Of those, 857 were either peri- or postmenopausal at the time of the survey. Additionally, 94.2 percent (n = 830) of respondents who completed the survey were age 46 or older at the time of the survey. In order to increase the response rate, women were given the opportunity to voluntarily enter themselves into a drawing for one of 10 Spa Finder gift certificates worth $100 each. Women who did not wish to enter the drawing were not required to participate. This survey was conducted by The North American Menopause Society and sponsored by the Alliance for Better Bone Health, an alliance between Procter & Gamble Pharmaceuticals, Inc. and sanofi-aventis US.
During the first five years after reaching menopause, women lose an average of 10 percent of their bone mass, making them more susceptible to osteoporosis. However, this survey showed that less than 10 percent of women reported being informed by their OB/GYNs that broken bones after menopause could be a sign of osteoporosis.
Studies have shown that in the US, over 70 percent of osteoporosis-related fractures and 94 percent of fracture costs are associated with nonspinal fractures. However, only 10 percent of women surveyed reported that their OB/GYNs have discussed the importance of preventing breaks in nonspinal bones.
The national survey results provided further insights into how women communicate with their OB/GYNs about osteoporosis.
- Almost half (46.8 percent) of women reported that they have never discussed their own personal risk of osteopenia or osteoporosis with their OB/GYN.
- Only a quarter of women reported that their OB/GYNs have told them that if left untreated, osteoporosis can lead to broken bones.
- While 62.5 percent of women reported that their OB/GYN has recommended a bone density test, 26.8 percent of women surveyed have never had one.
- Of the 45 women who experienced a broken bone over the past 5 years, in sites commonly associated with osteoporosis (hip, spine, wrist, collarbone, arm, leg, pelvis), over half (35 women) reported that their OB/GYN was unaware of this broken bone.
- While the majority of women surveyed reported that their OB/GYNs have told them that broken bones could be a consequence of osteoporosis, other potential consequences were not as well known, including loss of height, dowager’s hump, and disability or immobility.
A variety of doctors might diagnose and treat women for osteoporosis, but it is not specific to any one type of doctor or specialty. The goal of this survey was to determine how osteoporosis is being addressed by OB/GYNs specifically, as they are often the primary healthcare provider for women around the time of menopause when the risk of osteoporosis begins to increase.
The Alliance for Better Bone Health was formed in May 1997 to promote bone health and disease awareness through numerous activities to support physicians and patients around the globe. It is a collaboration between Procter & Gamble Pharmaceuticals, Inc. and sanofi-aventis U.S.
Read about perimenopause and menopause symptom relief in the NAMS Menopause Guidebook and Early Menopause Guidebook. For additional information about this survey or menopause in general, visit the Consumer page of our site.
Return to Menopause Flashes main page ► |